| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/01/2007 | US20070026418 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026417 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026416 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026415 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026414 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026413 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 02/01/2007 | US20070026407 Novel fine fluorescent particle |
| 02/01/2007 | US20070026405 Materials and methods for colorectal cancer screening, diagnosis and therapy |
| 02/01/2007 | US20070026399 Diagnosis of gynecological neoplasms by detecting the levels of oviduct-specific glycoprotein |
| 02/01/2007 | US20070026398 Protein tyrosine phosphatase-prl-1 a a marker and therapeutic target for pancreatic cancer |
| 02/01/2007 | US20070026395 Human cancer-relating genes, the products encoded thereby and applications thereof |
| 02/01/2007 | US20070026392 permit the assessment of agents without administration to subjects; using the artificial immune system of the invention for evaluating the potential reaction of a diseased animal to an agent |
| 02/01/2007 | US20070026389 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/01/2007 | US20070026388 Analyte detection using carbon nanotubes |
| 02/01/2007 | US20070026387 Diagnosing systemic lupus erythematosus (SLE); lymphocyte |
| 02/01/2007 | US20070026386 Method for the detection of newly acquired hiv infection |
| 02/01/2007 | US20070026385 Screening agents that modify association of Gs alpha with adenylyl cyclase or components of the plasma membrane or cytoskeleton; fluorescence resonance energy transfer |
| 02/01/2007 | US20070026384 Detection of transmembrane potentials by optical methods |
| 02/01/2007 | US20070026383 Methods and compositions for extracting membrane proteins |
| 02/01/2007 | US20070026382 Label-free, highly parallel, qualitative and quantitative detection of specific cell populations in a sample and for assessing cell functional status, cell-cell interactions and cellular responses to drugs, environmental toxins, bacteria, viruses and other factors that may affect cell function |
| 02/01/2007 | US20070026059 Ligands for orphan nuclear hormone receptor steroidogenic factor-1 (SF-1) |
| 02/01/2007 | US20070026029 Apheresis device |
| 02/01/2007 | US20070026020 Modified mycobacterium tuberculosis strains and uses thereof |
| 02/01/2007 | US20070026018 Methods for treating, preventing and diagnosing Helicobacter infection |
| 02/01/2007 | US20070026017 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 02/01/2007 | US20070026012 Compositions and methods for monitoring and altering protein folding and solubility |
| 02/01/2007 | US20070026011 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | US20070026003 Monoclonal antibodies; HCV enveloped subviral or purified HCV enveloped complete viral particles; hybridoma |
| 02/01/2007 | US20070025998 Methods for enhancing the efficacy of cancer therapy |
| 02/01/2007 | US20070025997 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/01/2007 | US20070025996 Oculospanin as a tumor specific antigen and methods and compositions utilizing same |
| 02/01/2007 | US20070025991 Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation |
| 02/01/2007 | US20070025971 Substances causing differentiation |
| 02/01/2007 | US20070025968 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| 02/01/2007 | US20070025962 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 02/01/2007 | US20070025955 Tissue adhesive sealant |
| 02/01/2007 | US20070025921 Inhibition of olfactory neurosensory function to treat eating disorders and obesity |
| 02/01/2007 | US20070025915 Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith |
| 02/01/2007 | US20070025914 Bronchioalveolar stem cells and uses thereof |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | US20070025911 Breast cancer; hybridomas; cell lines; kits |
| 02/01/2007 | US20070025879 Method and apparatus for syringe-based sample introduction within a flow cytometer |
| 02/01/2007 | US20070025878 Electronic device and thermal type flow meter on vehicle |
| 02/01/2007 | US20070025877 User interface for portable medical diagnostic apparatus and method of using the same |
| 02/01/2007 | US20070024844 Methods and apparatus for identifying live eggs |
| 02/01/2007 | US20070024843 Methods and apparatus for maintaining effective operation of apparatus for candling avian eggs |
| 02/01/2007 | US20070023628 Labeling agents for mass spectrometry comprising tertiary amines |
| 02/01/2007 | US20070023286 Field effect transistor; depositing solid layer of tin oxide on substrate board, placing beta-D-glucose oxidase and polyvinyl alcohol bearing styrylpyridinium groups in sulfuric acid, to form enzyme mixture, exposing to ultraviolet radiation, immersing in sulfuric acid buffer |
| 02/01/2007 | US20070023285 Three-dimensional bioelectrochemical sensor strip structure |
| 02/01/2007 | US20070022728 Method for determining the effects of fancy yarn |
| 02/01/2007 | DE202006012575U1 Test formulation, useful for fast albumin regulation in liquids, preferably urine, comprises concentrated reagent mixture containing precipitation agents, stabilizing materials, colorant, which reacts with protein, and Sephadex |
| 02/01/2007 | DE202006011233U1 Gel casting device for making cylindrical gel bodies has gel casting stage with cylindrical cavities of suitable defined geometry in which gels can be polymerized; polymerized gel cylinders can be removed from body with ejection stage |
| 02/01/2007 | DE19983372B4 Gasmischsystem und Verfahren Gas mixing system and method |
| 02/01/2007 | DE102005035238A1 Verfahren zur Überwachung und Steuerung der Wassergüte in Schwimmbädern Procedures for monitoring and control of water quality in swimming pools |
| 02/01/2007 | DE102005035086A1 Blood sugar measuring apparatus for monitoring or diagnosing diabetes with an analyzer for deriving insulin dose from the stored blood sugar value |
| 02/01/2007 | DE102005035058A1 Micromechanical device for e.g. air mass sensor, has reinforcement layer arranged in membrane to provide reinforcement in area of membrane edge, where membrane is made from dielectric layer, and layer is made from metal e.g. aluminum |
| 02/01/2007 | DE102005034217A1 System mit einem Abstrichinstrument für die Entnahme von Zellen oder das Auftragen von Präparaten sowie Aufnahmevorrichtung hierzu System with a swab instrument for the removal of cells or the application of preparations, as well as receiving device for this purpose |
| 02/01/2007 | DE102005017364B4 Analysegerät mit auswechselbarem Testfeldträger Analyzer with interchangeable test field support |
| 02/01/2007 | CA2654743A1 Oxidised phospholipids comprising a fluorophore moiety and use in the determination of the presence of enzymes having antiatherogenetic activity |
| 02/01/2007 | CA2617353A1 Graded expression of snail as marker of cancer development and dna damage-based diseases |
| 02/01/2007 | CA2617065A1 Coumarin-based amino acids for use in enzyme activity and substrate specificity assays |
| 02/01/2007 | CA2616985A1 Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-i-yl methylene or a pyrimidin-2yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group |
| 02/01/2007 | CA2616963A1 Stimulatory auto-antibodies to the pdgf receptor as pathology marker and therapeutic target |
| 02/01/2007 | CA2616770A1 Methods affecting markers in patients having vascular disease |
| 02/01/2007 | CA2616766A1 Antibody profiles characteristic of tuberculosis state |
| 02/01/2007 | CA2616552A1 Normalization of complex analyte mixtures |
| 02/01/2007 | CA2616497A1 Colon cancer related gene tom34 |
| 02/01/2007 | CA2616404A1 Nanoparticle probes for capture, sorting and placement of targets |
| 02/01/2007 | CA2616402A1 Method and system for checking an electromechanical biosensor |
| 02/01/2007 | CA2616189A1 Methods for reducing viral load in hiv-1-infected patients |
| 02/01/2007 | CA2616166A1 Heparin compositions and selectin inhibition |
| 02/01/2007 | CA2616099A1 Novel anti-igf-ir antibodies and uses thereof |
| 02/01/2007 | CA2615504A1 Multicellular metabolic models and methods |
| 02/01/2007 | CA2614935A1 Methods of detecting and treating acute kidney injury |
| 02/01/2007 | CA2609720A1 Gated amperometry |
| 02/01/2007 | CA2553487A1 Automated generation of multi-dimensional structure activity and structure property relationships |
| 01/31/2007 | EP1748297A1 Method for analysing naturally occuring peptides and small proteins using mass spectrometry |
| 01/31/2007 | EP1748296A1 Method for detecting GAD65 autoreactive T cells in newly diagnosed type 1 diabetic patients and in the prediabetic period |
| 01/31/2007 | EP1748295A1 System for manipulating magnetic particles |
| 01/31/2007 | EP1748294A2 In vivo model for immunocomparability |
| 01/31/2007 | EP1748082A1 Method of analyzing nucleic acid |
| 01/31/2007 | EP1748079A1 Kinase and phosphatase assays based on FRET |
| 01/31/2007 | EP1747784A1 Target gene mimitin of myc |
| 01/31/2007 | EP1747471A1 Microanalysis apparatus with constant pressure pump system |
| 01/31/2007 | EP1747469A1 Stimulated detection of sample compounds |
| 01/31/2007 | EP1747468A2 Disease related protein aggregation |
| 01/31/2007 | EP1747467A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 6 (dpp6) |
| 01/31/2007 | EP1747466A2 Method to predict prostate cancer |
| 01/31/2007 | EP1747465A2 Use of novel biomarkers for detection of testicular carcinoma in situ and derived cancers in human samples |
| 01/31/2007 | EP1747464A1 Methods for diagnosis of acute myeloid leukemia |
| 01/31/2007 | EP1747463A1 A method for detecting mycobacterial infection |
| 01/31/2007 | EP1747462A2 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 01/31/2007 | EP1747461A1 Magnetic particle detector system |
| 01/31/2007 | EP1747460A2 Method for a fully automated monoclonal antibody-based extended differential |
| 01/31/2007 | EP1747459A1 Multi-cellular test systems |
| 01/31/2007 | EP1747458A2 Fluid treatment apparatus with input and output fluid sensing |
| 01/31/2007 | EP1747455A2 Process for high throughput liquid or gas chromatography/mass spectrometry-based biomolecular screening for drug discovery |
| 01/31/2007 | EP1747451A2 Point of care heparin determination system |
| 01/31/2007 | EP1747450A1 Connector configuration for electrochemical cells and meters for use in combination therewith |